Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jeetvan G Patel, Anna D Coutinho, Orsolya E Lunacsek & Anand A Dalal. (2018) COPD affects worker productivity and health care costs. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2301-2311.
Read now
Read now
Ian M Breunig, Fadia T Shaya & Steven M Scharf. (2012) Delivering cost–effective care for COPD in the USA: recent progress and current challenges. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 725-731.
Read now
Read now
Dong-Churl Suh, Helen Lau, Hyen-Oh La, In-sun Choi & Gregory P. Geba. (2010) Association between incidence of acute exacerbation and medication therapy in patients with COPD. Current Medical Research and Opinion 26:2, pages 297-306.
Read now
Read now
Ilias I Siempos, Argyris Michalopoulos & Matthew E Falagas. (2009) Treatment of acute bacterial exacerbations of chronic bronchitis. Expert Opinion on Pharmacotherapy 10:7, pages 1173-1182.
Read now
Read now
Jennifer Petrillo & John Cairns. (2008) Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research 8:5, pages 453-461.
Read now
Read now
Articles from other publishers (12)
John R. Hurst, Jennifer K. Quint, Robert A. Stone, Yvonne Silove, Jane Youde & C. Michael Roberts. (2020) National clinical audit for hospitalised exacerbations of COPD. ERJ Open Research 6:3, pages 00208-2020.
Crossref
Crossref
Roberto Dal Negro. (2019) COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power. Healthcare 7:1, pages 35.
Crossref
Crossref
Roberto W. Dal Negro & Claudio F. Donner. 2018. Textbook of Pulmonary Rehabilitation. Textbook of Pulmonary Rehabilitation
273
282
.
Suman Kapur & Shivni Gupta. (2017) Indigenous rapid diagnostic technology for antibiotic susceptibility testing in urinary tract infection: from bench side to bedside. BMJ Innovations 3:1, pages 7-11.
Crossref
Crossref
A. Sicras, A. Huerta, R. Navarro & J. Ibañez. (2014) Uso de recursos y costes asociados a las exacerbaciones de enfermedad pulmonar obstructiva crónica: estudio retrospectivo de base poblacional. SEMERGEN - Medicina de Familia 40:4, pages 189-197.
Crossref
Crossref
Steven Simoens. (2013) Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. Journal of Evaluation in Clinical Practice 19:6, pages 1004-1011.
Crossref
Crossref
Steven Simoens. (2011) Factors Affecting the Cost Effectiveness of Antibiotics. Chemotherapy Research and Practice 2011, pages 1-6.
Crossref
Crossref
Jerneja Farkas, Mitja Kosnik, Matjaz Flezar, Stanislav Suskovic & Mitja Lainscak. (2010) Self-Rated Health Predicts Acute Exacerbations and Hospitalizations in Patients With COPD. Chest 138:2, pages 323-330.
Crossref
Crossref
G. Jébrak & M. Aubier. (2009) Exacerbations des bronchopneumopathies chroniques obstructives. EMC - Médecine d 'urgence 4:1, pages 1-16.
Crossref
Crossref
Manabu Akazawa, Sally C. Stearns & Andrea K. Biddle. (2008) Assessing Treatment Effects of Inhaled Corticosteroids on Medical Expenses and Exacerbations among COPD Patients: Longitudinal Analysis of Managed Care Claims. Health Services Research 43:6, pages 2164-2182.
Crossref
Crossref
Ya-hong CHEN, Wan-zhen YAO, Bai-qiang CAI, Hong WANG, Xiao-mei DENG, Hui-li GAO, Jia-sheng HUANG & Xin-mao WANG. (2008) Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chinese Medical Journal 121:7, pages 587-591.
Crossref
Crossref
R.W. Dal Negro, S. Tognella, R. Tosatto, M. Dionisi, P. Turco & C.F. Donner. (2008) Costs of chronic obstructive pulmonary disease (COPD) in Italy: The SIRIO study (Social Impact of Respiratory Integrated Outcomes). Respiratory Medicine 102:1, pages 92-101.
Crossref
Crossref